adyn

📍 Seattle, United States🗓 Founded 2020👥 9 employees💰 Last funded Jan 2024
Biotechnology Research🌐 adyn.com
Website LinkedIn
Founded by Dr. Elizabeth Ruzzo, adyn is helping people find birth control without side effects based on a persons genetic risk and hormone profile. Despite the 47M birth control users in the US, virtually no studies examine the biological factors that explain why individuals respond differently to a given contraceptive method. Launched in May 2022, The Birth Control Test is the first test designed to prevent birth control side effects. While we are improving the birth control experience, we are also committed to closing the gender health gap. By partnering with individuals, adyn leverages personal preference, medical history, and biological data to proactively help every (unique) body select the most desirable birth control option – with the least dangerous side effects. Our vision is to be earth’s most inclusive and patient-centric personalized medicine company. When a person uses The Birth Control Test, they can opt in as an anonymous research participant to help close these research gaps. This means you can simultaneously find the right birth control for your body, while helping others do the same.
3
Total investors
2
Early stage
1
Mid stage
0
Late stage
2020
Founded
Investors3 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
2
Brazil
1
Investor activity2020–2024 · investors recorded per year
202012021120241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in adyn?
adyn has 3 investors on record on gritt.io, including 2 early-stage backers, 1 mid-stage.
When did adyn last raise funding?
The most recent investment in adyn recorded on gritt.io was in January 2024.
When was adyn founded?
adyn was founded in 2020.
What industry is adyn in?
adyn operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is adyn based?
adyn is headquartered in Seattle, United States.